FDA — authorised 30 January 2012
- Application: NDA203388
- Marketing authorisation holder: GENENTECH
- Status: supplemented
🇺🇸 ERIVEDGE in United States
FDA authorised ERIVEDGE on 30 January 2012
Marketing authorisation
Other Oncology approved in United States
Frequently asked questions
Is ERIVEDGE approved in United States?
Yes. FDA authorised it on 30 January 2012.
Who is the marketing authorisation holder for ERIVEDGE in United States?
GENENTECH holds the US marketing authorisation.